Dr. Javed Butler invites you to our IV Iron CE symposium at the HFSA Annual Scientific Meeting in Atlanta, Georgia.
Sunday, September 29th
5:30pm - 6:30pm ET
Signia Hilton Atlanta
For more information and to register, visit https://t.co/9FLPw5Yj2l
#hfsa2024
It was a pleasure to collaborate with @JLHarrington_MD and @stormigale for a @CircHF review of "Anti-#Obesity Medications in Patients with #HF". https://t.co/U6jLpT4yWl. The new multi-disciplinary Metabolic HF Clinic @CleClinicHVTI is ramping up quickly with these protocols.
Save the date for a joint Critical Care/Cardiology PRN Virtual Webinar Program that is approved for 1-hour of ACPE CE!
Title: Managing the Failing Heart in the ICU: Tips and Tricks for Kick Starting the Heart
Register now: https://t.co/ZPo8HGIht7 (free for Card PRN members!)
Another summit (see what I did here?) in the HFpEF revolution! The dual GLP1/GIP mimetic tirzepatide improves outcomes in HFpEF with obesity!
SUMMIT trial showed 38% ⬇️ in HF outcomes (=time-to-first HFH, oral diuretic intensification and CV death)!! https://t.co/apLuJ4n2X4
A new paradigm for decongestion in acute #HeartFailure. Rapid uptitration of neurohormonal blockade after HF hospitalization is associated with effective, sustainable decongestion and better outcomes. https://t.co/GFXNTGgfeo
#JACC#STRONGHF@ppponikowski@DaniTomasoni_
🚨#FLOW: The most anticipated trial of the year now published in @NEJM with #ERA24
Semaglutide 1.0mg once weekly disease modifying with kidney, CV, & mortality benefits in people w T2D+CKD, cementing itself as a new pillar of care.
🧵 on key thoughts 👇🏾
https://t.co/5fbSxPSAMM
In #DICTATE trial, dapagliflozin was safe to start first day of AHF hospitalization before stabilization to optimize #GDMT & improve some measures of diuresis. #SGLT2i should be started immediately or continued in most pts hospitalized for AHF https://t.co/aSpTc3Pu6G #JACC@Zac0x
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee |
https://t.co/3UJMxlzLxs
@JJheart_doc @JACCJournals
HEART-FID (FCM in HFrEF + ID) on behalf of huge team #ESCCongress@escardio
FCM safe w modest benefit in hierarchical endpt (mortality, HF hosp, 6MWD)-Didn't meet pre-specified level of stat signif
https://t.co/cz3RUFYj9q
Pooled FCM data to contextualize
https://t.co/sR2eerpijT